Matthias Mack

2 Patents

• US123382802025

  Antibodies Targeting IL3

  UNIVERSITÄTSKLINIKUM REGENSBURG

  0 cites
• US121686922024

  Antibodies Targeting CCR2

  Granite Bio AG

  0 cites